Why is the market design for innovative pharmaceuticals not well understood?

J Comp Eff Res. 2024 Oct;13(10):e240105. doi: 10.57264/cer-2024-0105. Epub 2024 Sep 10.

Authors

Francisco Olivença¹, Jose Diaz², Sreeram V Ramagopalan^{1

3}, Louis P Garrison Jr⁴

Affiliations

¹ Lane Clark & Peacock LLP, London, W1U 1DQ, UK.
² Global Health Economics & Outcomes Research, Bristol Myers Squibb, Uxbridge, UB8 1DH, UK.
³ Centre for Pharmaceutical Medicine Research, King's College London, SE1 9NH, UK.
⁴ The Comparative Health Outcomes, Policy, & Economics (CHOICE) Institute, University of Washington, Seattle, WA 98195-7630, USA.

No abstract available

Keywords: innovation; market design; pharmaceuticals; pricing; research and development costs; value.

Publication types

Editorial

MeSH terms

Drug Industry* / economics
Humans
United States